Respiratory Disease Testing Market Expected to Reach USD 3.1 Billion Globally in 2022: Transparency Market Research
Respiratory disease tests are required for the diagnosis of any chronic or acute respiratory disorder. The diagnosis of respiratory function is done either by understanding the anatomy of the respiratory organs, or by determining the respiratory capabilities of the lungs. A majority of respiratory tests are designed either to identify obstructions in the respiratory tract, or to observe the efficiency of the lungs in exchanging respiratory gases.
View full press release